🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Two excellent healthcare VC ecosystem reports out today from SVB and HSBC. Both have great data and thoughtful perspectives on startup funding, exit environment, and trends/sub-sectors within healthcare... svb.com/globalassets/t… business.us.hsbc.com/en/campaigns/i…

Thanks for sharing Bruce Booth

Amazingly new data out today from Sweden 🇸🇪 showing an incredible decline in prevalence of the HPV virus as a result of the vaccine HPV causes cancer .. This is going to save a lot of lives Vaccines are incredible !

UK Research and Innovation has announced a new £9 million proof-of-concept fund to help convert world-class research into market-leading products and services. Find out more and apply at ukri.org/news/new-ukri-…

Made Front Page of Guardian today with treatment delay data RadiotherapyUK The Patrick G Johnston Centre for Cancer Research & have key paper The Lancet Oncology for World Cancer Day on new intelligence to inform National Cancer Plan which must be Big, Bold & Ambitious theguardian.com/society/2025/f… tomorrowspapers.co.uk/guardian-front…

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for individualised mRNA cancer immunotherapies. The eight-week consultation was will run until 31 March 2025. Find out more here gov.uk/government/new…

Research update from Dr Graeme Greenfield

We've been having a great time hosting the team from Manchester Cancer Research Centre as part of the #Fastman collaboration. Celebrating 10 years of amazing #prostatecancer research! #ProEx

Big Pharma M&A and licensing deal trends in 2025 Amidst turbulent markets, we've still seen robust activity. Some key stats: • 38 total deals (31 licensing and 7 M&A) • ~$60B in total deal volume (~$33B in licensing and ~$27B in M&A) • By volume, ~68% of deal assets were

Individualized #cancer #vaccines targeting #neoantigens have shown promise in small-scale studies, but the field is waiting on data from Merck's & Moderna's phase 3 trial of the #mRNA vaccine Intismeran autogene in #melanoma. Just out in Nature Biotechnology nature.com/articles/s4158…

Great article Cormac on the promise of exciting breakthrough treatments for cancer.

Pitchbook data on biotech fund raises by year via BioSpace. No wonder we've felt the pain of coming off 2018-2019 but it's looking quite anaemic now.

Great to see such progress, but we have a lot of work to do for patients with lung, oesphageal, liver and pancreatic cancers. Reflects the absolute importance of #ClinicalTrial in improving outcomes CancerTrialsIreland 🌈 Trinity St James's Cancer Institute Irish Research Radiation Oncology Group Irish Cancer Society

"Brexit has ruined this country, and now the majority of Britons thinks so too." RT if you are that majority.

CITY OF DERRY WALK - NOW ON A SUNDAY Join us on Sunday 14th September for a beautiful walk along the banks of the river Foyle. The perfect opportunity to get together with family and friend to help us mark blood cancer awareness month. llni.co.uk/event/city-of-… #BCAM2025

17 million people just lost health care. 18 million kids just lost school meals. 3 million Americans just lost food assistance. And $3.5 trillion was added to the deficit. All for a tax cut for Trump’s billionaire donors. The ultimate betrayal.

Great to see the UK Government’s Life Sciences Sector Plan published, which looks to harness UK science and innovation, strengthen the NHS and drive long-term economic growth. The UK Government’s ambition is that the UK will be the leading life sciences economy in Europe by 2030

🧬 The Future of Antibody-Drug Conjugates (ADCs): 2025-2035 ADCs are hitting their stride. From 15 approvals today to 40+ by 2035, they’re becoming one of the most powerful therapeutic platforms in biotech. Here’s a year-by-year breakdown of what’s coming next 👇🏼

Patent cliff pushing pharma companies earlier in deal making $XBI $IBB good summary by the FT

Absolutely fantastic news 👏 At all levels, commercialisation of good science, great teams both scientistifically and investment and great outcomes for patients and the pharma industry!